title: Tumour radiosensitization by nicotinamide: is it the result of an improvement in tumour oxygenation?
authors.affiliation: Danish Cancer Society, Department of Experimental Clinical Oncology, Aarhus.
authors.forename: M R
authors.initials: MR
authors.lastname: Horsman
authors.forename: M
authors.initials: M
authors.lastname: Nordsmark
authors.forename: A
authors.initials: A
authors.lastname: Khalil
authors.forename: D J
authors.initials: DJ
authors.lastname: Chaplin
authors.forename: J
authors.initials: J
authors.lastname: Overgaard
mesh_terms: D000818:Animals; D003131:Combined Modality Therapy; D005260:Female; D008325:Mammary Neoplasms, Experimental / Q000188:drug therapy* / Q000378:metabolism / Q000532:radiotherapy; D051379:Mice; D008809:Mice, Inbred C3H; D009536:Niacinamide / Q000494:pharmacology*; D010100:Oxygen / Q000378:metabolism*; D011838:Radiation-Sensitizing Agents / Q000494:pharmacology*
chemical_list: D011838:Radiation-Sensitizing Agents; D009536:Niacinamide; D010100:Oxygen